Drug-induced megaloblastic change.

Drug-induced hematologic syndromes. Adv Hematol (2009) 1.11

Dupuytren's contracture and alcohol. Ann Rheum Dis (1986) 0.88

Hematological side effects of co-trimoxazole. Infection (1987) 0.85

Changes in the mean corpuscular volume after capecitabine treatment are associated with clinical response and survival in patients with advanced gastric cancer. Cancer Res Treat (2014) 0.78

Antiepileptic drugs: a consideration of clinical and biochemical outcome in patients with epilepsy. Int J Prev Med (2013) 0.77

Drug-induced megaloblastic anemia. Dig Dis Sci (2005) 0.75

Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11

Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75

Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70

Translocation as a species conservation tool: status and strategy. Science (1989) 3.31

Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69

Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63

Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53

Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52

Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10

Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06

A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut (1999) 1.95

The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94

Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87

Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72

Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71

Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70

Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68

Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67

Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63

Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62

An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61

Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59

Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55

Localisation of the vaso-motor centre. J Physiol (1923) 1.51

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study. Gut (2001) 1.48

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47

The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42

In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol (1978) 1.39

Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38

Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37

The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34

Absence of oats toxicity in adult coeliac disease. BMJ (1996) 1.34

The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet (1981) 1.33

Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 1.29

Coeliac disease during the teenage period: the value of serial serum folate estimations. Gut (1974) 1.26

Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25

The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ (1999) 1.23

Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM (1997) 1.21

Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel. Clin Exp Immunol (1987) 1.19

Use of beta-lactamase to hydrolyse interfering antibiotics in vitamin B12 microbiological assay using Lactobacillus leichmannii. Clin Lab Haematol (1990) 1.18

Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum. Br J Haematol (1972) 1.18

Cellular response to alpha-gliadin in untreated coeliac disease. Gut (1982) 1.18

Folate coenzymes of Clostridium acidi-urici. The isolation of (l)-5,10-methenyltetrahydropteroyltriglutamate, its conversion to (l)-tetrahydropteroyltriglutamate and (l)-10-( 14 C)formyltetrahydropteroyltriglutamate, and the synthesis of (l)-10-formyl-(6,7- 3 H 2 )tetrahydropteroyltriglutamate and (l)-(6,7- 3 H 2 )tetrahydropteroyltriglutamate. J Biol Chem (1972) 1.17

Prevention of neural tube defects with folic acid a success but... QJM (1994) 1.17

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up. Gut (2003) 1.14

Homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 1.13

Trouble-free microbiologic serum and red cell folate assays. Am J Med Technol (1974) 1.13

Mechanism of choline O-sulphate utilization in fungi. Biochem J (1968) 1.13

Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet (1997) 1.13

Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) (1991) 1.11

Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease. Clin Exp Immunol (1981) 1.10

Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther (2008) 1.10

Microbiological assay for vitamin B12 with use of a colistin-sulfate-resistant organism. Clin Chem (1987) 1.10

Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem (1998) 1.10

A comparison of serum folate estimations using two different methods. J Clin Pathol (1973) 1.10

Malignant celiac syndrome. Report of two cases with malabsorption and microscopic foci of intestinal lymphoma. Gastroenterology (1970) 1.10

Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci (1991) 1.09

Suppressor-cell activity in coeliac disease induced by alpha-gliadin, a dietary antigen. Lancet (1984) 1.09

Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol (1991) 1.09

Oedema of the umbilical cord and respiratory distress in the newborn. Br J Obstet Gynaecol (1975) 1.08

Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Lab Clin Med (2001) 1.05

Monozygous anencephalic triplets--a case report. J Obstet Gynaecol Br Commonw (1966) 1.04

Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma(B). J Bacteriol (2001) 1.03

Complement activation within the coeliac small intestine is localised to Brunner's glands. Gut (1989) 1.01

Effect of bile on vitamin B12 absorption. Br Med J (1980) 1.01

The history of folic acid. Br J Haematol (2001) 1.00

Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J (2000) 1.00

Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull (1999) 0.99

Studies on derivation of transcobalamin 3 from granulocytes. Enhancement by lithium and elimination by fluoride of in vitro increments in vitamin B12-binding capacity. J Clin Invest (1974) 0.99

Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 0.99

Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J Cardiovasc Risk (1998) 0.98